Clinical Trial Update: A Phase Ib Study of AZD5004 in Chinese Participants With Overweight/Obesity With or Without Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A Phase Ib study evaluating the investigational drug AZD5004 in Chinese adults with overweight/obesity with or without Type 2 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD5004 (AZD5004)

Snippet

Sponsor: Eccogene | Conditions: Obesity or Overweight, Type 2 Diabetes | Phase 1 | Status: COMPLETED